Condition

DICER1 Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 3 DICER1 Syndrome clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Mexico (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest DICER1 Syndrome clinical trials

StudyPhaseWhereStatusRegistered
Understanding genetic causes of neuroendocrine tumors in Mexican patients — Mexico City, Mexico City and 2 other locations Recruiting Jul 26, 2024
Registry for rare lung tumors and DICER1-related conditions — Minneapolis, Minnesota Recruiting Dec 22, 2017
Investigating genetic factors in childhood cancer — Memphis, Tennessee Recruiting Feb 10, 2017

All recruiting trials (3)

Related topics

Li-Fraumeni SyndromeLynch SyndromeMultiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2NeuroblastomaTuberous SclerosisVon Hippel-Lindau DiseaseAcute LeukemiaAdrenocortical CarcinomaAMLDiamond Blackfan AnemiaDyskeratosis CongenitaFamilial Adenomatous PolyposisFanconi Anemia

Quick answers

How many DICER1 Syndrome clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Mexico (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.